These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 23841873)

  • 1. ASKP1240, a fully human anti-CD40 monoclonal antibody, prolongs pancreatic islet allograft survival in nonhuman primates.
    Watanabe M; Yamashita K; Suzuki T; Kamachi H; Kuraya D; Koshizuka Y; Ogura M; Yoshida T; Aoyagi T; Fukumori D; Shimamura T; Okimura K; Maeta K; Miura T; Sakai F; Todo S
    Am J Transplant; 2013 Aug; 13(8):1976-88. PubMed ID: 23841873
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term hepatic allograft acceptance based on CD40 blockade by ASKP1240 in nonhuman primates.
    Oura T; Yamashita K; Suzuki T; Fukumori D; Watanabe M; Hirokata G; Wakayama K; Taniguchi M; Shimamura T; Miura T; Okimura K; Maeta K; Haga H; Kubota K; Shimizu A; Sakai F; Furukawa H; Todo S
    Am J Transplant; 2012 Jul; 12(7):1740-54. PubMed ID: 22420525
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of ASKP1240 combined with tacrolimus or mycophenolate mofetil on renal allograft survival in Cynomolgus monkeys.
    Song L; Ma A; Dun H; Hu Y; Zeng L; Bai J; Zhang G; Kinugasa F; Sudo Y; Miyao Y; Okimura K; Miura T; Daloze P; Chen H
    Transplantation; 2014 Aug; 98(3):267-76. PubMed ID: 24992357
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combination therapy of an iNKT cell ligand and CD40-CD154 blockade establishes islet allograft acceptance in nonmyeloablative bone marrow transplant recipients.
    Kanzawa T; Hirai T; Fukuda H; Katsumata H; Ishii R; Ikemiyagi M; Ishii Y; Saiga K; Okumi M; Tanabe K
    Acta Diabetol; 2019 May; 56(5):541-550. PubMed ID: 30758788
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunosuppression With CD40 Costimulatory Blockade Plus Rapamycin for Simultaneous Islet-Kidney Transplantation in Nonhuman Primates.
    Oura T; Hotta K; Lei J; Markmann J; Rosales I; Dehnadi A; Kawai K; Ndishabandi D; Smith RN; Cosimi AB; Kawai T
    Am J Transplant; 2017 Mar; 17(3):646-656. PubMed ID: 27501203
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A human anti-CD40 monoclonal antibody, 4D11, for kidney transplantation in cynomolgus monkeys: induction and maintenance therapy.
    Aoyagi T; Yamashita K; Suzuki T; Uno M; Goto R; Taniguchi M; Shimamura T; Takahashi N; Miura T; Okimura K; Itoh T; Shimizu A; Furukawa H; Todo S
    Am J Transplant; 2009 Aug; 9(8):1732-41. PubMed ID: 19519810
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of ASKP1240, a fully human antibody targeting human CD40 with potent immunosuppressive effects.
    Okimura K; Maeta K; Kobayashi N; Goto M; Kano N; Ishihara T; Ishikawa T; Tsumura H; Ueno A; Miyao Y; Sakuma S; Kinugasa F; Takahashi N; Miura T
    Am J Transplant; 2014 Jun; 14(6):1290-9. PubMed ID: 24731050
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Costimulation blockade of both inducible costimulator and CD40 ligand induces dominant tolerance to islet allografts and prevents spontaneous autoimmune diabetes in the NOD mouse.
    Nanji SA; Hancock WW; Luo B; Schur CD; Pawlick RL; Zhu LF; Anderson CC; Shapiro AM
    Diabetes; 2006 Jan; 55(1):27-33. PubMed ID: 16380473
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel, blocking, Fc-silent anti-CD40 monoclonal antibody prolongs nonhuman primate renal allograft survival in the absence of B cell depletion.
    Cordoba F; Wieczorek G; Audet M; Roth L; Schneider MA; Kunkler A; Stuber N; Erard M; Ceci M; Baumgartner R; Apolloni R; Cattini A; Robert G; Ristig D; Munz J; Haeberli L; Grau R; Sickert D; Heusser C; Espie P; Bruns C; Patel D; Rush JS
    Am J Transplant; 2015 Nov; 15(11):2825-36. PubMed ID: 26139432
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prolonged survival of allogeneic islets in cynomolgus monkeys after short-term anti-CD154-based therapy: nonimmunologic graft failure?
    Koulmanda M; Smith RN; Qipo A; Weir G; Auchincloss H; Strom TB
    Am J Transplant; 2006 Apr; 6(4):687-96. PubMed ID: 16539625
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD40-specific costimulation blockade enhances neonatal porcine islet survival in nonhuman primates.
    Thompson P; Cardona K; Russell M; Badell IR; Shaffer V; Korbutt G; Rayat GR; Cano J; Song M; Jiang W; Strobert E; Rajotte R; Pearson T; Kirk AD; Larsen CP
    Am J Transplant; 2011 May; 11(5):947-57. PubMed ID: 21521467
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Islet allograft rejection in nonobese diabetic mice involves the common gamma-chain and CD28/CD154-dependent and -independent mechanisms.
    Demirci G; Strom TB; Li XC
    J Immunol; 2003 Oct; 171(7):3878-85. PubMed ID: 14500690
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of simultaneous CD154 and LFA-1 blockade on the survival of allogeneic islet grafts in nonobese diabetic mice.
    Berney T; Pileggi A; Molano RD; Poggioli R; Zahr E; Ricordi C; Inverardi L
    Transplantation; 2003 Dec; 76(12):1669-74. PubMed ID: 14688513
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Kidney Versus Islet Allograft Survival After Induction of Mixed Chimerism With Combined Donor Bone Marrow Transplantation.
    Oura T; Ko DS; Boskovic S; O'Neil JJ; Chipashvili V; Koulmanda M; Hotta K; Kawai K; Nadazdin O; Smith RN; Cosimi AB; Kawai T
    Cell Transplant; 2016; 25(7):1331-41. PubMed ID: 26337731
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nondepleting anti-CD40-based therapy prolongs allograft survival in nonhuman primates.
    Badell IR; Thompson PW; Turner AP; Russell MC; Avila JG; Cano JA; Robertson JM; Leopardi FV; Strobert EA; Iwakoshi NN; Reimann KA; Ford ML; Kirk AD; Larsen CP
    Am J Transplant; 2012 Jan; 12(1):126-35. PubMed ID: 21920020
    [TBL] [Abstract][Full Text] [Related]  

  • 16. D-dimer level, in association with humoral responses, negatively correlates with survival of porcine islet grafts in non-human primates with immunosuppression.
    Kang HJ; Lee H; Park EM; Kim JM; Min BH; Park CG
    Xenotransplantation; 2017 May; 24(3):. PubMed ID: 28417501
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of epitope-based ligation of ICAM-1 on survival and retransplantation of pig islets in nonhuman primates.
    Lee JI; Kim J; Choi YJ; Park HJ; Park HJ; Wi HJ; Yoon S; Shin JS; Park JK; Jung KC; Lee EB; Kang HJ; Hwang ES; Kim SJ; Park CG; Park SH
    Xenotransplantation; 2018 Jan; 25(1):. PubMed ID: 29131413
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Blockade of CD40-mediated signaling is sufficient for inducing islet but not skin transplantation tolerance.
    Phillips NE; Markees TG; Mordes JP; Greiner DL; Rossini AA
    J Immunol; 2003 Mar; 170(6):3015-23. PubMed ID: 12626555
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prolonged islet graft survival in NOD mice by blockade of the CD40-CD154 pathway of T-cell costimulation.
    Molano RD; Berney T; Li H; Cattan P; Pileggi A; Vizzardelli C; Kenyon NS; Ricordi C; Burkly LC; Inverardi L
    Diabetes; 2001 Feb; 50(2):270-6. PubMed ID: 11272136
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD154 blockade for induction of mixed chimerism and prolonged renal allograft survival in nonhuman primates.
    Kawai T; Sogawa H; Boskovic S; Abrahamian G; Smith RN; Wee SL; Andrews D; Nadazdin O; Koyama I; Sykes M; Winn HJ; Colvin RB; Sachs DH; Cosimi AB
    Am J Transplant; 2004 Sep; 4(9):1391-8. PubMed ID: 15307826
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.